Assessing the risk of transplant-related complications and individually tailoring the HSCT procedure in children and adolescents - Is it possible?

Bone Marrow Transplantation

Volumn 42, Issue SUPPL. 2, 2008, Pages

  Faraci, M ^a   Dini, G ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BLEOMYCIN; BUSULFAN; CARDIAC AGENT; CARMUSTINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IFOSFAMIDE; MELPHALAN; METHOTREXATE; PROCARBAZINE; STEROID; THIOTEPA;

BONE DISEASE; BRAIN TOXICITY; CARDIOTOXICITY; CATARACT; COMORBIDITY; ECHOCARDIOGRAPHY; FOLLOW UP; GENETIC PREDISPOSITION; GONADAL DISEASE; GRAFT VERSUS HOST REACTION; HEARING DISORDER; HEART DISEASE; HEART EJECTION FRACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; HLA MATCHING; HUMAN; HYPOTHYROIDISM; LIFE EXPECTANCY; LIVER TOXICITY; LOW DRUG DOSE; LUNG FUNCTION TEST; LUNG INSUFFICIENCY; NEPHROTOXICITY; OSTEOPOROSIS; OVARY INSUFFICIENCY; PNEUMONIA; POPULATION RISK; POSTOPERATIVE COMPLICATION; PREOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SURVIVAL RATE; THYROID DISEASE; THYROID FUNCTION; TOOTH DISEASE; WHOLE BODY RADIATION;

ADOLESCENT; ADOLESCENT DEVELOPMENT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MONITORING, PHYSIOLOGIC; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT;

EID: 55749102137     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.292     Document Type: Review

References (75)

1. Mullighan CG, Bardy PG. New directions in the genomics of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 127-144.
2. Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M et al. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiation Biol Phys 2005; 63: 1568-1575.
3. Tichelli A, Gratwohl A, Egger T, Roth J, Prunte A, Niessen C et al Cataract formation after bone marrow transplantation. Ann Intern Med 1993; 12: 1175-1180.
4. Tichelli A, Duell T, Weiss M, Socié G, Ljungman P, Cohen A et al Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: Incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant 1996; 17: 1105-1111.
5. Bylsma GW, Hall AJ, Szer J, West R. Atypical retinal microvasculopathy after bone marrow transplantation. Clin Experiment Ophthalmol 2001; 29: 225-229.
6. Eames GM, Crosson J, Steinberger J, Steinbuch M, Krabill K, Bass J et al. Cardiovascular function in children following bone marrow transplant: A cross sectional study. Bone Marrow Transplant 1997; 19: 61-66.
7. Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F et al. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: A prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplantation 2007; 39 667-675.
8. Mitsui H, Kitayama H, Yamagami T, Osuga Y, Teshima H, Ueda T et al Specific cardiomyopathy caused by high dose cyclophosphamide immediately after bone marrow transplantation. Rinsho Ketsueki 1989; 30: 387-391.
9. Leiper AD. Non-endocrine late complications of bone marrow transplantation in childhood: Part I. British J of Haematol 2002; 118: 3-22.
10. Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425-434.
11. Dvorak CC, Steinbach WJ, Brown JM, Agarwal R. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2005; 36: 621-629.
12. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H. Invasive fungal infections in pediatric bone marrow transplant recipients: Single center experience of 10 years. Bone Marrow Transplant 2000; 26: 999-1004.
13. Matsumoto M, Ishiguro H, Tomita Y, Inoue H, Yasuda Y, Shimizu T et al Changes in thyroid function after bone marrow transplant in young patients. Pediatr Int 2004; 46: 291-295.
14. Boulad F, Bromley M, Black P, Heller G, Sarafoglou K, Gillio A et al Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995; 15 71-76.
15. Sarafoglu K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukaemia during childhood. J Pediatr 1997; 130: 210-216.
16. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ et al. Pregnancy following high-dose cyclo-phosphamide with or without high dose busulfan or total body irradiation and bone marrow transplantation. Blood 1996; 87: 3045-3052.
17. Barker CC, Butzner JD, Anderson RA, Brant R, Sauve RS. Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2003; 32: 79-87.
18. Reiss U, Cowan M, McMillan A, Horn B. Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 2002; 24: 746-750.
19. Horn B, Reiss U, Matthay K, McMillan A, Cowan M..Venoocclusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: A high incidence in patients with neuroblastoma. Bone Marrow Transplant 2002; 29 409-415.
20. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007; 137: 81.
21. Tomás JF, Pinilla I, García-Buey ML, García A, Figuera A, Gómez-García de Soria VGG et al. Long-term liver dysfunction after allogeneic bone marrow transplantation: Clinical features and course in 61 patients. Bone Marrow Transplant 2000; 26: 649-655.
22. Matthes-Martin S, Lamche M, Ladenstein R, Emminger W, Felsberger C, Topf R et al. Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: A single centre retrospective analysis. Bone Marrow Transplant 1999; 23: 1049-1053.
23. Socié G, Cahn Y, Carmelo J, Vernant JP, Jouet JP, Ifrah N et al Avascular necrosis of bone after allogeneic bone marrow transplantation: Analysis of risk factors for 4388 patients by the Societé Francaise de Greffe de Moëlle (SFGM). British J of Haematol 1997; 97: 865-870.
24. Torii Y, Hasegawas Y, Kubo T, Kodera Y, Minami S, Morishita Y et al Osteonecrosis of the femoral head after allogeneic bone marrow transplantation. Clinical Orthopaed and Related Research 2001; 382: 124-132.
25. Cesaro S, Brugiolo A, Faraci M, Uderzo C, Rondelli R, Favre C et al Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: A survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant 2003; 32: 925-931.
26. Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RG, van Oostayen JA et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002; 17: 1032-1037.
27. Kist-van Holthe JE, van Zwet JML, Brand R, van Weel MH, Vossen JM, van der Heijden AJ. Bone marrow transplantation in children: Consequences for renal function shortly after and 1 year post BMT. Bone Marrow Transplantation 1998; 22: 559-564.
28. Faraci M, Lanino E, Dini G, Fondelli MP, Morreale G, Dallorso S et al Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 2002; 59: 1895-1904.
29. Thompson CB, Sanders JE, Flournoy N, Buckner CD, Thomas ED. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. Blood 1986; 67 195-199.
30. Gurney JG, Ness KK, Rosenthal J, Forman SJ, Bhatia S, Baker KS. Visual, auditory, sensory, and motor impairments in long-term survivors of haematopoietic stem cell transplantation performed in childhood: Results from the Bone Marrow Transplant Survivor study. Cancer 2006; 106: 1402-1408.
31. Belkacémi Y, Touboul E, Méric JB, Rat P, Warnet JM. Radiation-induced cataract: Physiopathologic, radiobiologic and clinical aspects. Cancer Radiother 2001; 5: 397-412.
32. www.survivorshipguidelines.org.
33. Fahnehjelm KT, Törnquist AL, Olsson M, Winiarski J. Visual outcome and cataract development after allogeneic stem-cell transplantation in children. Acta Ophthalmol Scand 2007; 85: 724-733.
34. Leiper AD. Non-endocrine late complications of bone marrow transplantation in childhood: Part II. British J of Haematol 2002; 118: 23-43.
35. van Kempen-Harteveld ML, van Weel-Sipman MH, Emmens C, Noordijk EM, van der Tweel I, Révész T et al. Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: Risks and benefits. Bone Marrow Transplant 2003; 31: 1151-1156.
36. Benyunes MC, Sullivan KM, Deeg HJ, Mori M, Meyer W, Fisher L et al Cataracts after bone marrow transplantation: Long-term follow-up of adults treated with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 1995; 32: 661-670.
37. Hinkle AS, Proukou CB, Deshpande SS, Duffy SA, Kozlowski AM, French CA et al. Cardiotoxicity caused by chemotherapy. In: Wallace H, Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 4a, pp 85-100.
38. Erkus B, Demirtas S, Yarpuzlu AA, Can M, Genc Y, Karaca L. Early prediction of anthracycline induced cardiotoxicity. Acta Paediatr 2007; 96: 506-509.
39. Rovelli A, Pezzini C, Silvestri D, Tana F, Galli MA, Uderzo C. Cardiac and respiratory function after bone marrow transplantation in children with leukemia. Bone Marrow Transplant 1995; 16: 571-576.
40. Candoni A, Michelutti A, Simeone E, Damiani D, Baccarani M, Fanin R. Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins. Eur J Haematol 2006; 77: 293-299.
41. Cerveri I, Zoia MC, Fulgoni P, Corsico A, Casali L, Tinelli C et al Late pulmonary sequelae after childhood bone marrow transplantation. Thorax 1999; 54: 131-135.
42. Ferry C, Gemayel G, Rocha V, Labopin M, Esperou H, Robin M et al. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant 2007; 40: 219-224.
43. Neyssa M, Sharis C, Tarbell N. Respiratory complications. In: Wallace H, Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 5, pp 114-122.
44. Sipsas NV, Kontoyiannis DP. Clinical issue regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with haematological malignancies. Clin Infect Dis 2006; 42: 1584-1591.
45. Cesaro S, Cecchetto G, De Corti F, Dodero P, Giacchino M, Caviglia I et al. Results of a multicenter retrospective study of a combined medical and surgical approach to pulmonary aspergillosis in pediatric neutropenic patients. Pediatr Blood Cancer 2007; 49: 909-913.
46. Al-Fiar FZ, Colwill R, Lipton JH, Fules G, Spaner D, Messner H. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19 1019-1022.
47. Critchley HOD, Thomson AB, Wallace WHB. Ovarian and uterine function and reproductive potential. In: Wallace H, Green D (eds). Late Effects of Childhood Cancer. Arnold London, 2004, chapter 8c, pp 225-238.
48. Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K et al Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988; 6: 813-818.
49. Wallace WHB, Thompson AB, Kelsey TW. Radiosensitivity of the human oocyte. Hum Reprod 2003; 18: 117-121.
50. Spinelli S, Chiodi S, Bacigalupo A, Brasca A, Menada MV, Petti AR et al. Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: Long-term follow-up of 79 females. Bone Marrow Transplant 1994; 14: 373-380.
51. Socié G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A et al. A for the Late Effect Working Party of the European Group for Blood and Marrow Transplantation: Nonmalignant late effects after allogeneic stem cell transplantation, Review Article. Blood 2003; 101: 3373-3385.
52. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant 2006; 37: 249-261.
53. Thomson AB, Hamish W, Wallace B, Sklar C. Testicular function. In: Wallace H, Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 8d, pp 240-256.
54. Bahadur G, Ozturk O, Muneer A, Wafa R, Ashraf A, Jaman N et al. Semen quality before and after gonadotoxic treatment. Hum Reprod 2005; 20: 774-781.
55. Saito K, Suzuki K, Iwasaki A, Yumura Y, Kubota Y. Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer 2005; 104: 521-524.
56. Radich JP, Sanders JE, Buckner CD, Martin PJ, Petersen FB, Bensinger W et al. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. J Clin Oncol 1993; 11: 304-313.
57. Strasser SI, Myerson D, Spurgeon CL, Sullivan KM, Storer B, Schoch HG et al. Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10-year follow-up. Hepatology 1999; 29: 1893-1899.
58. Lucarelli G, Clift RA, Galimberti M, Polchi P, Angelucci E, Baronciani D et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood 1996; 87: 2082-2088.
59. Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T et al Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: Incidence, onset time and risk factors. Bone Marrow Transplant 1998; 22 1191-1197.
60. Wadleigh M, Richardson PG, Zahrieh D, Lee SJ, Cutler C, Ho V et al Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. Blood, 2003; 102: 1578-1582.
61. Meresse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugieres L et al. Risk factors for hepatic venoocclusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: A study in 136 children. Bone Marrow Transplant 1992; 10: 135-141.
62. Schulz AS, Classen CF, Mihatsch WA, Sigl-Kraetzig M, Wiesneth M, Debatin KM et al. HLA-haploidentical blood progenitor cell transplantation in osteopetrosis. Blood 2002; 99: 3458-3460.
63. Ljungman P, Engelhard D, de la Cámara R, Einsele H, Locasciulli A, Martino R et al. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Vaccination of stem cell transplant recipients: Recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737-746.
64. Faraci M, Calevo MG, Caruso S, Lanino E, Messina C, Favre C et al. Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy. Haematologica 2006; 91: 1096-1099.
65. Skinner R. Renal damage. In: Wallace H, Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 6a, pp 125-137.
66. Frisk P, Bratteby LE, Carlson K, Lönnerholm G. Renal function after autologous bone marrow transplantation in children: A long-term prospective study. Bone Marrow Transplant 2002; 29: 129-136.
67. Kist-van Holthe JE, Bresters D, Ahmed-Ousenkova YM, Goedvolk CA, Abbink FC, Wolterbeek R et al. Long-term renal function after hemopoietic stem cell transplantation in children. Bone Marrow Transplant 2005; 36: 605-610.
68. Cool VA. Long-term neuropsychological risks in pediatric bone marrow transplant: What do we know? Bone Marrow Transplant 1996; 18 (Suppl 3): S45-S49.
69. Coradini PP, Cigana L, Selistre SG, Rosito LS, Brunetto AL. Ototoxicity from cisplatin therapy in childhood cancer. J Pediatr Hematol Oncol 2007; 29: 355-360.
70. Sonis AL. Craniofacial development,teeth and salivary gland. In: Wallace H and Green D (eds). Late Effects of Childhood Cancer. Arnold: London, 2004, chapter 7d, pp 176-185.
71. Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: Influence of pretransplantation co-morbidities. Blood 2004; 104: 961-968.
72. Alamo J, Shahjahan M, Lazarus HM, de Lima M, Giralt SA. Comorbidity indices in hematopoietic stem cell transplantation: A new report card. Bone Marrow Transplant 2005; 36: 473-474.
73. http://ctep.cancer.gov/reporting/ctc.html.
74. Stein J, Dini G, Yaniv I, Pediatric Diseases Working Party of the EBMT. The hope and the reality of reduced intensity transplants in children with malignant diseases. Bone Marrow Transplant 2005; 35 (Suppl 1): S39-S43.
75. Del Toro G, Satwani P, Harrison L, Cheung YK, Brigid Bradley M, George D et al. A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant 2004; 33: 613-622.